File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/S0920-9964(98)00032-2
- Scopus: eid_2-s2.0-0032572611
- PMID: 9713904
- WOS: WOS:000075204800004
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Meta-analysis of studies on genetic variation in 5-HT(2A) receptors and clozapine response
Title | Meta-analysis of studies on genetic variation in 5-HT(2A) receptors and clozapine response |
---|---|
Authors | |
Keywords | 5-HT(2A) Clozapine Schizophrenia Serotonin |
Issue Date | 1998 |
Publisher | Elsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/schres |
Citation | Schizophrenia Research, 1998, v. 32 n. 2, p. 93-99 How to Cite? |
Abstract | Serotonin (5-HT) neurotransmitter receptors are targeted by atypical antipsychotic drugs. We hypothesized that genetic variation in these receptors may affect clinical response to the drugs targeting them. This hypothesis has been tested by several studies in which the correlation between polymorphic variants in the 5-HT(2A) receptor gene and clinical response to the atypical antipsychotic clozapine was investigated. The results of these studies either found association between 5-HT(2A) genetic variants and clozapine response or found differences in the same direction which did not reach statistical significance. Meta-analysis of these studies including 373 patients who responded to the treatment and 360 non-responders showed association between two 5-HT(2A) polymorphisms, 102-T/C and His452Tyr, and clozapine response. Statistical analysis of extreme responders showed a clearer association of the 102-T/C with clozapine response. These results reinforce the hypothesis and strengthen the candidacy of these receptors as important therapeutic targets. |
Persistent Identifier | http://hdl.handle.net/10722/175795 |
ISSN | 2023 Impact Factor: 3.6 2023 SCImago Journal Rankings: 1.374 |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Arranz, MJ | en_US |
dc.contributor.author | Munro, J | en_US |
dc.contributor.author | Sham, P | en_US |
dc.contributor.author | Kirov, G | en_US |
dc.contributor.author | Murray, RM | en_US |
dc.contributor.author | Collier, DA | en_US |
dc.contributor.author | Kerwin, RW | en_US |
dc.date.accessioned | 2012-11-26T09:01:21Z | - |
dc.date.available | 2012-11-26T09:01:21Z | - |
dc.date.issued | 1998 | en_US |
dc.identifier.citation | Schizophrenia Research, 1998, v. 32 n. 2, p. 93-99 | en_US |
dc.identifier.issn | 0920-9964 | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/175795 | - |
dc.description.abstract | Serotonin (5-HT) neurotransmitter receptors are targeted by atypical antipsychotic drugs. We hypothesized that genetic variation in these receptors may affect clinical response to the drugs targeting them. This hypothesis has been tested by several studies in which the correlation between polymorphic variants in the 5-HT(2A) receptor gene and clinical response to the atypical antipsychotic clozapine was investigated. The results of these studies either found association between 5-HT(2A) genetic variants and clozapine response or found differences in the same direction which did not reach statistical significance. Meta-analysis of these studies including 373 patients who responded to the treatment and 360 non-responders showed association between two 5-HT(2A) polymorphisms, 102-T/C and His452Tyr, and clozapine response. Statistical analysis of extreme responders showed a clearer association of the 102-T/C with clozapine response. These results reinforce the hypothesis and strengthen the candidacy of these receptors as important therapeutic targets. | en_US |
dc.language | eng | en_US |
dc.publisher | Elsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/schres | en_US |
dc.relation.ispartof | Schizophrenia Research | en_US |
dc.subject | 5-HT(2A) | - |
dc.subject | Clozapine | - |
dc.subject | Schizophrenia | - |
dc.subject | Serotonin | - |
dc.subject.mesh | Alleles | en_US |
dc.subject.mesh | Antipsychotic Agents - Pharmacology | en_US |
dc.subject.mesh | Clozapine - Pharmacology | en_US |
dc.subject.mesh | Genetic Variation - Genetics | en_US |
dc.subject.mesh | Genotype | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Polymorphism, Genetic | en_US |
dc.subject.mesh | Receptor, Serotonin, 5-Ht2a | en_US |
dc.subject.mesh | Receptors, Serotonin - Genetics | en_US |
dc.title | Meta-analysis of studies on genetic variation in 5-HT(2A) receptors and clozapine response | en_US |
dc.type | Article | en_US |
dc.identifier.email | Sham, P: pcsham@hku.hk | en_US |
dc.identifier.authority | Sham, P=rp00459 | en_US |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.doi | 10.1016/S0920-9964(98)00032-2 | en_US |
dc.identifier.pmid | 9713904 | - |
dc.identifier.scopus | eid_2-s2.0-0032572611 | en_US |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-0032572611&selection=ref&src=s&origin=recordpage | en_US |
dc.identifier.volume | 32 | en_US |
dc.identifier.issue | 2 | en_US |
dc.identifier.spage | 93 | en_US |
dc.identifier.epage | 99 | en_US |
dc.identifier.isi | WOS:000075204800004 | - |
dc.publisher.place | Netherlands | en_US |
dc.identifier.scopusauthorid | Arranz, MJ=7006010757 | en_US |
dc.identifier.scopusauthorid | Munro, J=7102726057 | en_US |
dc.identifier.scopusauthorid | Sham, P=34573429300 | en_US |
dc.identifier.scopusauthorid | Kirov, G=26643478800 | en_US |
dc.identifier.scopusauthorid | Murray, RM=35406239400 | en_US |
dc.identifier.scopusauthorid | Collier, DA=26642980600 | en_US |
dc.identifier.scopusauthorid | Kerwin, RW=7102904567 | en_US |
dc.identifier.issnl | 0920-9964 | - |